BRPI0700969A - composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia - Google Patents

composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia

Info

Publication number
BRPI0700969A
BRPI0700969A BRPI0700969-0A BRPI0700969A BRPI0700969A BR PI0700969 A BRPI0700969 A BR PI0700969A BR PI0700969 A BRPI0700969 A BR PI0700969A BR PI0700969 A BRPI0700969 A BR PI0700969A
Authority
BR
Brazil
Prior art keywords
bacterial
treatment
composition
inflammatory conditions
inflammatory
Prior art date
Application number
BRPI0700969-0A
Other languages
English (en)
Inventor
Neto Dolivar Coraucci
Original Assignee
Ouro Fino Participacoes E Empr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ouro Fino Participacoes E Empr filed Critical Ouro Fino Participacoes E Empr
Priority to BRPI0700969-0A priority Critical patent/BRPI0700969A/pt
Priority to US12/532,065 priority patent/US8536143B2/en
Priority to PCT/BR2008/000085 priority patent/WO2008113149A2/en
Publication of BRPI0700969A publication Critical patent/BRPI0700969A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSIçãO PARA O TRATAMENTO DE AFECçõES BACTERIANAS E INFLAMATóRIAS EM ANIMAIS DE COMPANHIA. A presente invenção refere-se a uma nova composição de macrolídeo, das classes das azalídas denominado Azitromicina, associado um antiínfiamatório não esterálde, o Meloxícam, destinada para animais de companhia, particularmente em cães e gatos, para o tratamento de afecções bactenanas e inflamatónas que acometem cães e gatos Esta invenção visa proporcionar antibioticoterapia de amplo espectro, combatendo a causa das infecções, enquanto trata a inflamação e seus efeitos.
BRPI0700969-0A 2007-03-22 2007-03-22 composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia BRPI0700969A (pt)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BRPI0700969-0A BRPI0700969A (pt) 2007-03-22 2007-03-22 composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia
US12/532,065 US8536143B2 (en) 2007-03-22 2008-03-24 Compositions to treat bacterial and inflammatory affections in pet animals dosage form and method to treat pet animals
PCT/BR2008/000085 WO2008113149A2 (en) 2007-03-22 2008-03-24 Observations where certain claims were found unsearchable

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0700969-0A BRPI0700969A (pt) 2007-03-22 2007-03-22 composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia

Publications (1)

Publication Number Publication Date
BRPI0700969A true BRPI0700969A (pt) 2008-11-04

Family

ID=39766524

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0700969-0A BRPI0700969A (pt) 2007-03-22 2007-03-22 composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia

Country Status (3)

Country Link
US (1) US8536143B2 (pt)
BR (1) BRPI0700969A (pt)
WO (1) WO2008113149A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
WO2011107150A1 (en) * 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20130121916A1 (en) * 2010-03-10 2013-05-16 Sergio Baroni Compositions for Colon Lavage and Methods of Making and Using Same
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
CN107281155B (zh) * 2017-06-06 2020-04-10 扬子江药业集团四川海蓉药业有限公司 一种阿奇霉素片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69524214T3 (de) * 1994-05-06 2008-05-15 Pfizer Inc. Azithromycin enthaltende arzneiverabreichungsformen mit gesteuerter wirkstoffabgabe
TW200403072A (en) 2002-01-23 2004-03-01 Upjohn Co Combination therapy for the treatment of bacterial infections
US20040214753A1 (en) 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
CA2542509A1 (en) 2003-10-29 2005-05-19 Idexx Laboratories, Inc. Salts of pharmacologically active compounds
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US20060058247A1 (en) 2004-09-16 2006-03-16 Yujiro Hata Methods and compositions for treating cystic fibrosis
US20060205682A1 (en) 2005-02-25 2006-09-14 Roberts Richard H Antibiotic and combinations of antibiotic and symptomatic relief agent formulations

Also Published As

Publication number Publication date
US20100173858A1 (en) 2010-07-08
WO2008113149A3 (en) 2008-11-06
US8536143B2 (en) 2013-09-17
WO2008113149A2 (en) 2008-09-25

Similar Documents

Publication Publication Date Title
CR10310A (es) Compuestos nuevos
BRPI0923855A8 (pt) Ácido lipóico, e, composição de ração de animal de estimação
GT200100036A (es) Derivados de eteres de pirazol como agentes antiinflamatorios / analgesicos.
MX2016015326A (es) Combinacion, composicion y metodo de administracion de la combinacion o composicion a animales.
BR112012016146A2 (pt) uso de piruvatos na preparação de composições para animais de estimação
BRPI0807790A2 (pt) Composição de ração para animal de estimação, e, uso da mesma
BRPI0806517A2 (pt) Método para chocar ovos de chocadeira, composição formulada para o tratamento de ovos de chocadeira antes da incubação, e, uso de uma composição
NO20081000L (no) Anvendelse av aureolysininhibitor for behandling av inflammatoriske hudsykdommer karakterisert ved kolonisering med Staphylococcus Aureus
NO20076463L (no) Synergetiske kombinasjoner
WO2008113149A3 (en) Observations where certain claims were found unsearchable
ECSP088922A (es) Derivados de amino-tiazol y sus usos como agentes antibacterianos
BRPI0416731A (pt) métodos para a redução de quantidade de desulfovibrio e/ou helicobacter spp. no trato gi de um animal de estimação, para tratamento de uma inflamação do trato gi em um animal de estimação, e para a redução de um odor
BR112013018557A2 (pt) método de tratamento de infecções
CL2009000065A1 (es) Proteina aislada que comprende una pluralidad de dominios rrl para utilizarse como agente anti-microbiano; composicion farmaceutica que comprende dicha proteina aislada; metodo para tratar infeccion microbiana.
BR112014011601A2 (pt) bidens pilosa e compostos poliacetilênicos para a prevenção e para o tratamento de coccidiose
NI200800167A (es) Composición veterinaria compuesta por sal orgánica de levamisol combinada con por lo menos una avermectina y/o milbemicina.
BRPI1014505A2 (pt) métodos e composições para tratar e previnir infecção por escherichia coli produtora de toxina shiga.
BR112012025772A2 (pt) métodos de controle e profilaxia de inflamação e mitigação de condições inflamatórias em animais de estimação
BR112014014036A8 (pt) composição antibacteriana de timol e totarol
BRPI0806095A2 (pt) associação farmacêutica, composições de uso tópico, formas de dosagens e método para o tratamento de otites agudas ou crÈnicas em animais de companhia
Roy et al. Investigation of the aetiology of udder-thigh dermatitis in French dairy cattle
CU20100119A7 (es) Compuestos orgánicos de aminotiazoles
BR112015004152A2 (pt) combinação farmacêutica compreendendo um inibidor de fosfatidilinositol 3-quinase e um inibidor da aromatase
AR055161A1 (es) Combinacion de metionina biodisponible con por lo menos un aceite esencial
BR112016007057A2 (pt) um método veterinário para induzir êmese

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B11K Dismissal acc. art. 17, par 2 of ipl - pending earlier application (priority claim) definitively shelved

Free format text: PRIORIDADE INTERNA DO PI0801222-9.

B03G Publication of an application: publication cancelled [chapter 3.7 patent gazette]

Free format text: REFERENTE A RPI 1974 DE 04/11/2008.

B03F Publication of an application: publication of application definitely dismissed [chapter 3.6 patent gazette]